ð§ã»ãªã¢ãã¯ç ãšè³è žçžé¢ã®æ°ããªèŠç¹ïŒé·æã°ã«ãã³ããªãŒé£ã§ãç¶ãäžèª¿ã®è¬ãè§£ãæãã
ã»ãªã¢ãã¯ç ã¯ãå°éºŠãªã©ã«å«ãŸããã°ã«ãã³ãæåããããšã§å°è žã«ççãèµ·ãããæ é€åžåã劚ããããèªå·±å ç«çŸæ£ã§ãããã®ç æ°ã®æ²»çã«ã¯ãçæ¶¯ã«ããã峿 Œãªã°ã«ãã³ããªãŒé£ïŒGFDïŒãäžå¯æ¬ ãšãããŠããŸããããããGFDãé·æéç¶ããŠããã«ããããããããè ¹ã®äžèª¿ãå šèº«ã®åŠæ æãªã©ãããŸããŸãªçç¶ã«æ©ãŸããç¶ããæ£è ãããå°ãªããããŸããããªãããã®ãããªçç¶ãç¶ãã®ã§ããããïŒè¿å¹Žããã®åå ã®äžã€ãšããŠãè³ãšè žã®çžäºäœçšã®ç°åžžïŒDGBIïŒããæ³šç®ãããŠããŸãã
ã»ãªã¢ãã¯ç ãšã¯ïŒ
ã»ãªã¢ãã¯ç ã¯ãéºäŒççŽ å ãæã€äººãã°ã«ãã³ãæåããããšã§ãå°è žã®ç²èãæå·ãåããæ é€çŽ ã®åžåãé»å®³ãããç æ°ã§ããäžç¢ãè ¹çã䟿ç§ãªã©ã®æ¶ååšçç¶ã ãã§ãªããè²§è¡ãç²åŽæãäœéæžå°ã骚ç²ãããçãç®èçç¶ãªã©ãå šèº«ã«ããã倿§ãªçç¶ãåŒãèµ·ããããšããããŸããçŸåšã®ãšãããå¯äžã®æ²»çæ³ã¯ã°ã«ãã³ãå®å šã«é€å»ããé£äºãããªãã¡ã°ã«ãã³ããªãŒé£ãçæ¶¯ç¶ããããšã§ãã
è³ãšè žã®çžäºäœçšã®ç°åžžïŒDGBIïŒãšã¯ïŒ
ç§ãã¡ã®è³ãšè žã¯ãèªåŸç¥çµããã«ã¢ã³ãå ç«ç³»ãªã©ãä»ããŠå¯æ¥ã«é£æºããäºãã«åœ±é¿ãåã£ãŠããŸããããããè³è žçžé¢ããšåŒã³ãŸããDGBIïŒDisorders of Gut-Brain InteractionïŒã¯ããã®è³ãšè žã®ã³ãã¥ãã±ãŒã·ã§ã³ã«äœããã®ç°åžžãçããããšã§ãæ¶ååšçç¶ãæ ¢æ§çã«çŸããç æ ã®ç·ç§°ã§ãã以åã¯ãæ©èœæ§æ¶åç®¡çŸæ£ããšåŒã°ããŠããŸããããè³ãšè žã®çžäºäœçšã®éèŠæ§ãèªèãããDGBIãšããåç§°ã䜿ãããããã«ãªããŸãããéææ§è žçå矀ïŒIBSïŒãªã©ã代衚çãªDGBIã®äžã€ã§ãã
æ¬ç ç©¶ã¯ãé·æã«ããã£ãŠã°ã«ãã³ããªãŒé£ãç¶ããŠããã»ãªã¢ãã¯ç æ£è ããã«ãããŠããã®DGBIé¢é£ã®çç¶ãã©ããããèŠãããã®ãããããŠãããæ£è ããã®ç掻ã®è³ªïŒQOLïŒã«ã©ã®ããã«åœ±é¿ããŠããã®ããæããã«ããããã«è¡ãããŸããã
ð¬ç ç©¶ã®ç®çãšæ¹æ³
ç ç©¶ã®ç®ç
ãã®ç ç©¶ã®äž»ãªç®çã¯ãé·æã«ãããã°ã«ãã³ããªãŒé£ãéµå®ããŠããã»ãªã¢ãã¯ç ã®æäººæ£è ããã«ãããŠããè³ãšè žã®çžäºäœçšã®ç°åžžïŒDGBIïŒãã«åèŽããçç¶ãããã¡ã€ã«ãã©ããããã®å²åã§ååšãããããããŠãããã®çç¶ãã©ã®ãããªèŠå ãšé¢é£ããŠããããè©äŸ¡ããããšã§ããã
ç ç©¶ã®æ¹æ³
- 察象è ïŒãªã©ã³ãã®ã»ãªã¢ãã¯ç åäŒã«æå±ããæäººäŒå¡ããªã³ã©ã€ã³ã¢ã³ã±ãŒãã«åçããŸããããã®ãã¡ãã»ãªã¢ãã¯ç ãšèšºæããããã€1幎以äžã°ã«ãã³ããªãŒé£ã峿 Œã«éµå®ããŠãã1001人ãç ç©¶ã®å¯Ÿè±¡ãšãªããŸããã察象è ã®çŽ79.3%ã女æ§ã§ã幎霢ã®äžå€®å€ã¯50æ³ã§ããã
- 調æ»å 容ïŒã¢ã³ã±ãŒãã«ã¯ãDGBIã®èšºæã«çšããããåœéçãªåºæºã§ãããRome IV蚺æè³ªå祚ããå«ãŸããŠããŸãããããã«å ããŠãå¿ççèŠçïŒäžå®ãæãã€ãªã©ïŒãæ¶ååšä»¥å€ã®èº«äœçç¶ã®éç床ããããŠå¥åº·é¢é£ã®ç掻ã®è³ªïŒQOLïŒãè©äŸ¡ããããã®æ€èšŒæžã¿ã®è³ªå祚ãçšããããŸããã
- å¯Ÿç §çŸ€ïŒãªã©ã³ãã®äžè¬äœæ°ã察象ãšããå¥ã®ã³ããŒãç ç©¶ã®ããŒã¿ããæ¯èŒã®ããã®å¯Ÿç §çŸ€ãšããŠäœ¿çšãããŸãããããã«ãããã»ãªã¢ãã¯ç æ£è ããã®DGBIé¢é£çç¶ã®æç çããäžè¬ã®äººã ãšæ¯ã¹ãŠã©ã®çšåºŠé«ãã®ãã客芳çã«è©äŸ¡ããããšãã§ããŸããã
ðé©ãã®ç ç©¶çµæïŒDGBIçç¶ã®é«ã
ãã®ç ç©¶ãããé·æã°ã«ãã³ããªãŒé£ãç¶ããŠããã»ãªã¢ãã¯ç æ£è ããã®éã§ãDGBIé¢é£ã®çç¶ãéåžžã«é«ãé »åºŠã§èŠãããããšãæããã«ãªããŸããã
äž»èŠãªçºèŠ
ç ç©¶ã®çµæãã»ãªã¢ãã¯ç æ£è ããã®çŽ64.8%ããå°ãªããšã1ã€ä»¥äžã®DGBIã«åèŽããçç¶ãããã¡ã€ã«ãæã£ãŠããããšã倿ããŸãããããã¯ãå¯Ÿç §çŸ€ïŒäžè¬äœæ°ïŒã®31.3%ãšæ¯èŒããŠãéåžžã«é«ãå²åã§ããçµ±èšçã«èª¿æŽããããªããºæ¯ïŒAORïŒã§ã¯ãã»ãªã¢ãã¯ç æ£è ãããDGBIé¢é£çç¶ãæã€ãªã¹ã¯ã¯ãäžè¬äœæ°ã®çŽ3.2åã«ããªãããšã瀺ãããŸããã
ç¹ã«æ³šç®ãã¹ãã¯ãDGBIã®äžã§ããéææ§è žçå矀ïŒIrritable Bowel Syndrome, IBSïŒããšã®é¢é£ãæã匷ãã£ãããšã§ããã»ãªã¢ãã¯ç æ£è ãããIBSã®çç¶ãããã¡ã€ã«ãæã€ãªã¹ã¯ã¯ãäžè¬äœæ°ã®çŽ4.5åã«ãäžããŸããã
ããã«ãDGBIé¢é£ã®çç¶ãããã¡ã€ã«ãæã€ã»ãªã¢ãã¯ç æ£è ããã¯ãå¯Ÿç §çŸ€ãšåæ§ã«ãããé«ãã¬ãã«ã®å¿ççèŠçïŒã¹ãã¬ã¹ãäžå®ãæãã€ãªã©ïŒããæ¶ååšä»¥å€ã®èº«äœçç¶ïŒé çãçèçãç²åŽæãªã©ïŒã®éçåºŠãæ±ããŠãããå¥åº·é¢é£ã®ç掻ã®è³ªïŒQOLïŒãèããäœãããšãæããã«ãªããŸããã
äž»èŠçµæã®æŠèŠ
| é ç® | ã»ãªã¢ãã¯ç æ£è (n=1001) | å¯Ÿç §çŸ€ (äžè¬äœæ°) | 調æŽãªããºæ¯ (95%ä¿¡é Œåºé) |
|---|---|---|---|
| 1ã€ä»¥äžã®DGBIçç¶ãããã¡ã€ã«ã«åèŽ | 64.8% | 31.3% | 3.2 (2.6-3.8) |
| éææ§è žçå矀 (IBS) ã«åèŽ | ïŒå ·äœçãªå²åã¯æé²ã«èšèŒãªãïŒ | ïŒå ·äœçãªå²åã¯æé²ã«èšèŒãªãïŒ | 4.5 (3.3-6.2) |
| DGBIçç¶ãšé¢é£ããèŠçŽ | é«ãå¿ççèŠçãé«ãéæ¶ååšç³»èº«äœçç¶ãäœãå¥åº·é¢é£QOL | ||
â»DGBIïŒDisorders of Gut-Brain InteractionïŒïŒè³ãšè
žã®çžäºäœçšã®ç°åžžã以åã¯æ©èœæ§æ¶åç®¡çŸæ£ãšåŒã°ããŠããŸããã
â»èª¿æŽãªããºæ¯ïŒAORïŒïŒä»ã®åœ±é¿èŠå ïŒå¹Žéœ¢ãæ§å¥ãªã©ïŒãèæ
®ããŠç®åºããããããäºè±¡ãèµ·ãããªã¹ã¯ã®æ¯çã
â»95%ä¿¡é ŒåºéïŒCIïŒïŒçã®å€ã95%ã®ç¢ºçã§ãã®ç¯å²å
ã«ãããšæšå®ãããåºéã
ð¡ç ç©¶çµæã瀺åããããšïŒèå¯
ãã®ç ç©¶çµæã¯ãé·æã«ãããã°ã«ãã³ããªãŒé£ãéµå®ããŠããã»ãªã¢ãã¯ç æ£è ããã§ãã£ãŠããå€ãã®äººãæç¶çãªæ¶ååšçç¶ãå šèº«çç¶ã«æ©ãŸãããŠããçŸç¶ãæµ®ã圫ãã«ããŸããããããŠããã®åå ãšããŠDGBIãéèŠãªåœ¹å²ãæãããŠããå¯èœæ§ã瀺åããŠããŸãã
- ã°ã«ãã³ããªãŒé£ã ãã§ã¯äžååãªå ŽåãããïŒã»ãªã¢ãã¯ç ã®æ²»çã®åºæ¬ã¯ã°ã«ãã³ããªãŒé£ã§ããããã®ç ç©¶ã¯ãããã ãã§ã¯ãã¹ãŠã®çç¶ã解決ããªãã±ãŒã¹ãå°ãªããªãããšã瀺ããŠããŸããç¹ã«ãDGBIé¢é£ã®çç¶ã¯ãã°ã«ãã³ã®æåãšã¯ç°ãªãã¡ã«ããºã ã§çããŠããå¯èœæ§ããããŸãã
- éææ§è žçå矀ãšã®åŒ·ãé¢é£ïŒã»ãªã¢ãã¯ç æ£è ããã«ãããéææ§è žçå矀ïŒIBSïŒã®æç çãéåžžã«é«ãããšã¯ã泚ç®ãã¹ãç¹ã§ããIBSã¯ä»£è¡šçãªDGBIã®äžã€ã§ãããè žã®åããæèŠã®ç°åžžãè žå 现èå¢ã®å€åããããŠè³è žçžé¢ã®ä¹±ããªã©ãè€éã«çµ¡ã¿åã£ãŠçºçãããšèããããŠããŸããã»ãªã¢ãã¯ç ã«ãã£ãŠå°è žãæå·ãåããçµéšããæ ¢æ§çãªççããIBSã®ãããªDGBIãçºçããããäœè³ªãäœãåºããŠããã®ãããããŸããã
- å¿èº«ã®å¥åº·ãžã®åœ±é¿ïŒDGBIé¢é£çç¶ããå¿ççèŠçãæ¶ååšä»¥å€ã®èº«äœçç¶ã®éç床ããããŠç掻ã®è³ªã®äœäžãšåŒ·ãé¢é£ããŠããããšã¯ããããã®çç¶ãåãªãããè ¹ã®äžèª¿ãã«ãšã©ãŸãããæ£è ããã®å¿èº«å šäœã«å€§ããªåœ±é¿ãäžããŠããããšã瀺ããŠããŸããæ ¢æ§çãªçç¶ã¯ã¹ãã¬ã¹ãšãªãããããããã«è³è žçžé¢ãä¹±ããçç¶ãæªåããããšããæªåŸªç°ã«é¥ãå¯èœæ§ããããŸãã
- 蚺æãšæ²»çã«ãããDGBIã®èæ ®ïŒãã®ç ç©¶çµæã¯ãã»ãªã¢ãã¯ç æ£è ãããã°ã«ãã³ããªãŒé£ãç¶ããŠãçç¶ãæ¹åããªãå ŽåãDGBIã®å¯èœæ§ãç©æ¥µçã«æ€èšããå¿ èŠãããããšã匷ã瀺åããŠããŸããDGBIã«å¯Ÿããé©åãªèšºæãšæ²»çã¢ãããŒãïŒäŸãã°ãé£äºçæ³ãè¬ç©çæ³ãå¿ççæ³ãªã©ïŒãå°å ¥ããããšã§ãæ£è ããã®çç¶ç·©åãšQOLåäžã«ç¹ããå¯èœæ§ããããŸãã
ãã ãããã®ç ç©¶ã§ã¯ãæ£è ãããç¡æèã«ã°ã«ãã³ãæåããŠããå¯èœæ§ããã»ãªã¢ãã¯ç 以å€ã®ä»ã®äœµåçŸæ£ãçç¶ã«åœ±é¿ãäžããŠããå¯èœæ§ãå®å šã«æé€ããããšã¯ã§ããŸããã§ããããããã®éçãèžãŸãã€ã€ãDGBIãã»ãªã¢ãã¯ç æ£è ããã®æç¶çç¶ã®éèŠãªèŠå ã§ãããšããç¥èŠã¯ãä»åŸã®èšºçã«å€§ããªåœ±é¿ãäžãããšèããããŸãã
ðã»ãªã¢ãã¯ç æ£è ããã®å®ç掻ã¢ããã€ã¹
ããããªããã»ãªã¢ãã¯ç ã§ãã°ã«ãã³ããªãŒé£ãç¶ããŠããã«ããããããããè ¹ã®äžèª¿ãå šèº«ã®åŠæ æãªã©ã®çç¶ã«æ©ãŸãããŠãããªãããã®ç ç©¶çµæã¯ããªãã ãã§ã¯ãªãããšã瀺ããŠããŸãããããŠãDGBIãšããæ°ããªèŠç¹ããçç¶ãæããããšã§ãæ¹åãžã®éãéãããããããŸããã
- å»åž«ãšã®ã³ãã¥ãã±ãŒã·ã§ã³ãå¯ã«ïŒçç¶ãç¶ãå Žåã¯ãé æ ®ãªã䞻治å»ã«çžè«ããŸããããã°ã«ãã³ããªãŒé£ã®éµå®ç¶æ³ã ãã§ãªããå ·äœçãªçç¶ã®å 容ãé »åºŠãçæŽ»ãžã®åœ±é¿ãªã©ã詳ããäŒããããšãéèŠã§ãã
- çç¶æ¥èšãã€ããŠã¿ãŸãããïŒãã€ãã©ã®ãããªçç¶ããã©ã®çšåºŠã®åŒ·ãã§çŸãããããã®æã®é£äºå 容ãã¹ãã¬ã¹ã¬ãã«ãªã©ãèšé²ããããšã§ãçç¶ã®ãã¿ãŒã³ãèªå ãèŠã€ããæãããã«ãªããŸããããã¯ãå»åž«ãDGBIã®èšºæãæ²»çæ¹éãæ€èšããäžã§éåžžã«åœ¹ç«ã¡ãŸãã
- ã¹ãã¬ã¹ç®¡çãæèããïŒDGBIã¯ã¹ãã¬ã¹ãšå¯æ¥ã«é¢é£ããŠããŸãããã€ã³ããã«ãã¹ãçæ³ããšã¬ãæ·±åŒåžãè¶£å³ã®æéãªã©ãèªåã«åã£ãã¹ãã¬ã¹è§£æ¶æ³ãèŠã€ããŠå®è·µããŸããããååãªç¡ç ãéèŠã§ãã
- å¿ççãµããŒãã®æ€èšïŒæ ¢æ§çãªçç¶ã¯ãäžå®ãæãã€ãšãã£ãå¿ççèŠçãåŒãèµ·ããããããã®ã§ããå¿ èŠã§ããã°ãå¿çå ç§å»ãã«ãŠã³ã»ã©ãŒãªã©ãå¿ã®å°éå®¶ãžã®çžè«ãæ€èšããŠã¿ãŸããããå¿ççæ³ïŒèªç¥è¡åçæ³ãªã©ïŒãDGBIã®çç¶æ¹åã«æå¹ã§ããããšãç¥ãããŠããŸãã
- é£ç掻以å€ã®çæŽ»ç¿æ £ãèŠçŽãïŒé©åºŠãªéåãèŠåæ£ããçæŽ»ãªãºã ãååãªæ°Žåæåãªã©ãåºæ¬çãªå¥åº·ç¿æ £ãè žã®å¥åº·ã«åœ±é¿ãäžããŸãã
- DGBIã«è©³ããå°éå»ãžã®çžè«ïŒãã䞻治å»ãDGBIã®å°éã§ãªãå Žåãæ¶ååšå ç§ã®äžã§ãæ©èœæ§æ¶åç®¡çŸæ£ãDGBIã«è©³ããå»åž«ã玹ä»ããŠãããããšãäžã€ã®éžæè¢ã§ãã
â ïžç ç©¶ã®éçãšä»åŸã®èª²é¡
æ¬ç ç©¶ã¯ãé·æã°ã«ãã³ããªãŒé£ã®ã»ãªã¢ãã¯ç æ£è ã«ãããDGBIã®æç çãšé¢é£èŠå ãæããã«ããäžã§éèŠãªç¥èŠãæäŸããŸããããããã€ãã®éçãååšããŸãã
- ã°ã«ãã³æé²ã®å¯èœæ§ïŒåå è ãã°ã«ãã³ããªãŒé£ããéµå®ããŠããããšèªå·±ç³åããŠããŸãããæå³ããªãã°ã«ãã³ã®æåïŒäº€å·®æ±æãªã©ïŒãå®å šã«æé€ãããããã§ã¯ãããŸããã埮éã®ã°ã«ãã³æé²ãæç¶çãªçç¶ã®åå ãšãªã£ãŠããå¯èœæ§ãåŠå®ã§ããŸããã
- ä»ã®äœµåçŸæ£ã®åœ±é¿ïŒã»ãªã¢ãã¯ç 以å€ã®ä»ã®ç æ°ïŒäŸãã°ãç²ç¶è ºçŸæ£ãç³å°¿ç ãªã©ïŒã䜵åããŠããå Žåããããã®çŸæ£ãæ¶ååšçç¶ãå šèº«çç¶ã«åœ±é¿ãäžããŠããå¯èœæ§ãèæ ®ããå¿ èŠããããŸããæ¬ç ç©¶ã§ã¯ããããã®äœµåçŸæ£ã®åœ±é¿ãå®å šã«æé€ããããšã¯ã§ããŸããã§ããã
- èªå·±ç³ååŒã®ããŒã¿ïŒã¢ã³ã±ãŒã圢åŒã®èª¿æ»ã§ãããããçç¶ã®è©äŸ¡ãã°ã«ãã³ããªãŒé£ã®éµå®ç¶æ³ãèªå·±ç³åã«åºã¥ããŠããŸããããã«ããã客芳çãªè©äŸ¡ãšã®éã«ãããçããå¯èœæ§ããããŸãã
- å æé¢ä¿ã®ç¹å®ïŒæ¬ç ç©¶ã¯æšªæç ç©¶ã§ãããDGBIé¢é£çç¶ãšQOLäœäžãªã©ã®é¢é£æ§ã瀺ããŸããããã©ã¡ããåå ã§ã©ã¡ããçµæã§ããããšããæç¢ºãªå æé¢ä¿ãç¹å®ããããšã¯ã§ããŸããã
ä»åŸã®ç ç©¶ã§ã¯ããããã®éçãå æããDGBIãã»ãªã¢ãã¯ç æ£è ã®çç¶ã«ã©ã®ããã«åœ±é¿ããŠããã®ãããã®ã¡ã«ããºã ãããã«æ·±ãè§£æããŠããå¿ èŠããããŸããäŸãã°ãè žå 现èå¢ã®å€åãè žã®ééæ§ãå ç«ç³»ã®æŽ»æ§åãªã©ããã詳现ãªççåŠçã»çç©åŠçããŒã«ãŒãçšããç ç©¶ãæ±ããããŸãããŸããDGBIã«å¯Ÿããåå¥åãããæ²»çæŠç¥ã®éçºãéèŠãªèª²é¡ãšãªãã§ãããã
ãŸãšãïŒã»ãªã¢ãã¯ç æ£è ã®æç¶çç¶ã«ã¯ãè³ãšè žã®çžäºäœçšã®ç°åžžãã®èŠç¹ãäžå¯æ¬
ä»åã®ç ç©¶ã¯ãé·æã«ãããã°ã«ãã³ããªãŒé£ãéµå®ããŠããã»ãªã¢ãã¯ç æ£è ããã®çŽ3åã®2ããè³ãšè žã®çžäºäœçšã®ç°åžžïŒDGBIïŒã«åèŽããçç¶ãããã¡ã€ã«ãæã£ãŠããããšãæããã«ããŸãããããã¯äžè¬ã®äººã ãšæ¯èŒããŠçŽ3.2åãé«ãå²åã§ãããç¹ã«éææ§è žçå矀ãšã®é¢é£ã匷ãããšã瀺ãããŸããããããã®DGBIé¢é£çç¶ã¯ãæ£è ããã®å¿ççèŠçãæ¶ååšä»¥å€ã®èº«äœçç¶ã®éç床ãšé¢é£ããçæŽ»ã®è³ªïŒQOLïŒãèããäœäžãããŠããããšã倿ããŸããããã®çµæã¯ãã»ãªã¢ãã¯ç æ£è ãããã°ã«ãã³ããªãŒé£ãç¶ããŠãçç¶ãæ¹åããªãå ŽåãDGBIã®å¯èœæ§ãç©æ¥µçã«èæ ®ãããã®èšºæãšæ²»çãæ€èšããããšããæ£è ããã®QOLåäžã«ãšã£ãŠæ¥µããŠéèŠã§ããããšã匷ã瀺åããŠããŸããã»ãªã¢ãã¯ç ã®èšºçã«ãããŠãæ¶ååšçç¶ã ãã§ãªããå¿èº«å šäœã«ãããã¢ãããŒããæ±ããããæä»£ãæ¥ãŠãããšèšããã§ãããã
é¢é£ãªã³ã¯é
- æ¥æ¬æ¶ååšç åŠäŒ
- æ¥æ¬æ¶ååšå èŠé¡åŠäŒ
- åœç«åœéå»çç ç©¶ã»ã³ã¿ãŒ æ¶ååšå ç§
- åçåŽåç
- Celiac Disease Foundation (ç±³åœ)
- Coeliac UK (è±åœ)
æžèªæ å ±
| DOI | 10.1002/ueg2.70311 |
|---|---|
| PMID | 42888891 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/42888891/ |
| çºè¡å¹Ž | 2026 |
| èè å | van Gils Tom, Törnblom Hans, van Overveld Floris, Palsson Olafur S, Sperber Ami D, Bangdiwala Shrikant I, Trindade Inês A, Benninga Marc A, Bouma Gerd, Simrén Magnus |
| èè æå± | Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Dutch Coeliac Society, Naarden, the Netherlands.; University of North Carolina/Chapel Hill, Chapel Hill, North Carolina, USA.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.; EMBRACE Lab, Center for Health and Medical Psychology, Ãrebro University, Ãrebro, Sweden.; Department of Paediatric Gastroenterology, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, the Netherlands. |
| éèªå | United European Gastroenterol J |